Why respiratory pharmacology items are really safety items
Respiratory medication questions look like drug recall questions, but the underlying skill being tested is client safety. Nearly every distractor in this content area describes a client who has confused a controller medication with a rescue medication, who is using an inhaler incorrectly, or who has stopped a daily medication because breathing improved. Recognising the pattern lets you answer confidently even when the exact drug is unfamiliar.
Start every respiratory drug item by classifying the medication into one of three buckets: it opens airways quickly, it reduces inflammation over time, or it prevents the inflammatory cascade from starting. Once the bucket is clear, the safe answer follows. A drug that opens airways quickly is the one you reach for in acute distress. A drug that reduces inflammation is the one that must be taken every day whether or not symptoms exist.
The second recurring skill is expected-versus-adverse effect discrimination. Beta-2 agonists stimulate receptors that are not exclusive to the lung, so mild tachycardia, fine tremor and jitteriness are predictable and do not require stopping the drug. Chest pain, a heart rate above 120 or new dysrhythmias do require reporting. Being able to draw that line separates a passing answer from a panicked one.
- •Bucket one — rapid airway opening: albuterol, levalbuterol, ipratropium
- •Bucket two — anti-inflammatory control: fluticasone, budesonide, oral prednisone
- •Bucket three — cascade prevention: montelukast, cromolyn, omalizumab
- •Ask first: is this client in distress right now, or being taught for the long term?
Bronchodilators: short-acting, long-acting and anticholinergic
Short-acting beta-2 agonists relax bronchial smooth muscle within minutes and last four to six hours. Albuterol is the exam's default rescue drug, and any stem describing acute wheeze, chest tightness or an asthma attack that offers albuterol as an option is usually pointing there. The teaching emphasis is that increasing rescue inhaler use — more than twice a week for asthma — signals poor control and must be reported, because it predicts an exacerbation.
Long-acting beta-2 agonists such as salmeterol and formoterol take much longer to work and last twelve hours. They are maintenance drugs only. The most heavily tested safety point in this class is that a long-acting beta agonist must never be used as monotherapy in asthma and must never be used to treat an acute attack; if a client reports using salmeterol for sudden wheeze, the correct response is to teach that the short-acting inhaler is the rescue medication.
Anticholinergic bronchodilators such as ipratropium and tiotropium block muscarinic receptors and are especially useful in chronic obstructive pulmonary disease. Their side effects follow the classic anticholinergic pattern — dry mouth, blurred vision, urinary retention and constipation — so a client with benign prostatic hyperplasia or narrow-angle glaucoma needs closer monitoring. Sipping water and using sugar-free lozenges is the standard teaching answer for dry mouth.
| Class | Examples | Role | Key safety point |
|---|---|---|---|
| Short-acting beta-2 agonist | Albuterol, levalbuterol | Rescue in acute bronchospasm | Rising use signals worsening control |
| Long-acting beta-2 agonist | Salmeterol, formoterol | Twice-daily maintenance | Never for rescue; never alone in asthma |
| Short-acting anticholinergic | Ipratropium | Rescue adjunct, mainly COPD | Dry mouth; caution in glaucoma and BPH |
| Long-acting anticholinergic | Tiotropium | Once-daily COPD maintenance | Capsule is inhaled, never swallowed |
| Methylxanthine | Theophylline | Rarely used maintenance | Narrow range 10–20 mcg/mL; avoid caffeine |
Corticosteroids and the drugs that prevent inflammation
Inhaled corticosteroids are the backbone of long-term asthma control. They take days to weeks to reach full effect, which is exactly why the exam tests whether the client understands that the drug must be taken daily even when breathing feels normal. A client who states they use their steroid inhaler only when short of breath has demonstrated a need for further teaching, and that option is almost always the answer.
The dominant local adverse effect is oropharyngeal candidiasis, caused by steroid deposition in the mouth. The prevention bundle is short and highly testable: use a spacer, rinse the mouth with water after each dose, and spit rather than swallow. Hoarseness and white patches on the tongue or buccal mucosa are the findings that should prompt a report.
Systemic corticosteroids such as prednisone are used in short bursts for exacerbations. Their tested points are hyperglycaemia in diabetic clients, gastric irritation that calls for administration with food, immunosuppression that mutes infection signs, and the absolute rule that long-term therapy is tapered rather than stopped abruptly to allow adrenal recovery.
Leukotriene modifiers such as montelukast are oral preventive agents taken in the evening. They are useful for exercise-induced and allergic asthma but have no rescue role. The neuropsychiatric warning — new agitation, mood change, sleep disturbance or suicidal thinking — is a legitimate reporting trigger and appears in newer question banks.
- •Daily controller adherence is the single most tested teaching concept
- •Spacer plus rinse-and-spit prevents thrush
- •Monitor blood glucose closely when systemic steroids are added
- •Montelukast is preventive only and is dosed in the evening
Inhaler technique, peak flow and the teaching answers examiners reward
Inhaler technique questions are free points if you memorise the sequence. Shake the metered-dose inhaler, exhale fully away from the device, place the mouthpiece correctly or use a spacer, inhale slowly and deeply while actuating, hold the breath for about ten seconds, then wait roughly one minute between puffs. Dry powder inhalers differ in one important way: they require a quick, forceful inhalation and must never be shaken or exhaled into, because moisture clumps the powder.
Peak expiratory flow monitoring is the asthma action plan's backbone. The client establishes a personal best, then interprets readings by zone. Green is eighty percent or more of personal best and means continue the current plan. Yellow is fifty to seventy-nine percent and means use the rescue inhaler and follow the action plan. Red is below fifty percent and means take the rescue medication and seek immediate care.
Finally, expect at least one item that tests escalation judgement. A client using a rescue inhaler with no relief, sitting in a tripod position, speaking in single words, or showing a suddenly silent chest is deteriorating. A silent chest in a previously wheezing asthmatic is an ominous finding indicating minimal air movement, and it requires immediate intervention rather than continued observation.
- •MDI: shake, exhale, slow deep inhale, hold ten seconds, wait one minute
- •DPI: do not shake, do not exhale into device, inhale quickly and forcefully
- •Peak flow zones: green 80%+, yellow 50–79%, red under 50%
- •Silent chest, single-word speech or tripod positioning means escalate now